Most clients tolerate NAD+ injections very well
This review integrates current evidence on how brain peptides contribute to AD pathophysiology, summarizes recent progress in peptide-based therapeutic strategies and delivery platforms, and critically examines the remaining barriers to clinical translation, including bloodbrain barrier penetration, metabolic stability, off-target effects, and the need for biomarker-guided patient stratification
BPC-157 (CAS 137525-51-0), also known as Body Protection Compound-157, Bepecin, and PL 14736, is a synthetic pentadecapeptide with the molecular formula CHNO and a molecular weight of 1419.55 g/mol
Pharmacol Ther 137(1):100107
(PubMed) Other Rare but Reported Risks Severe skin reactions including serious allergic or hypersensitivity reactions